From the Journals

Heart rate changes during sleep may be diagnostic tool for depression


 

FROM BMC PSYCHIATRY

A heart rate–profiling algorithm shows promise at distinguishing differences in heart rate patterns during sleep between people with depression and healthy controls, research shows.

The algorithm was modeled using machine learning based on 1,203 polysomnograms from either people with depression or healthy controls, according to Mysa Saad, of the sleep research unit of the Royal’s Institute of Mental Health Research in Ottawa, and associates. That final algorithm was then tested on a new sample of 174 individuals (87 controls, 87 with depression) to categorize each person as either depressed or not depressed. This result was compared with medical record diagnoses. The study was published in BMC Psychiatry.

Compared with the control group, patients in the depression group slept 30.6 minutes less, had significantly longer sleep and REM onset latency, and had a lower amount of REM sleep as a percentage of total sleep time and in overall time. The algorithm incorrectly identified 15 patients with depression as being in the control group, and incorrectly identified 20 controls as having depression. The overall accuracy was 79.9%, with a sensitivity of 82.8% and a specificity of 77%.

“In addition to providing an improved biological underpinning for the diagnosis of depression, this [tool] could possibly offer supplemental information to psychiatric clinical assessment, and objective measures for early screening. Moreover, the use of distinct physiological variables as biomarkers of depression may help emphasize the interactions between mental and physical health. This may contribute to reducing the stigma associated with depression, lifting some social barriers to accessing psychiatric treatment, and allowing for more holistic patient care,” the investigators concluded.

Medibio provided partial funding for the salaries of research assistants; no other conflicts of interest were reported.

SOURCE: Saad M et al. BMC Psychiatry. 2019 Jun 7. doi: 10.1186/s12888-019-2152-1.

Recommended Reading

Evidence lacking for using cannabinoids to treat mental disorders
MDedge Family Medicine
What’s the proper place of benzodiazepines in psychiatry?
MDedge Family Medicine
CBT and antidepressants have similar costs for major depressive disorder
MDedge Family Medicine
Reappraising standard treatment of comorbid insomnia/depression
MDedge Family Medicine
More adolescents seek medical care for mental health issues
MDedge Family Medicine
Suicide screening crucial in pediatric medical settings
MDedge Family Medicine
ACGME deepening its commitment to physician well-being, leader says
MDedge Family Medicine
Higher risk of bipolar disorder, depression, anxiety found with autism
MDedge Family Medicine
Fast-tracking psilocybin for refractory depression makes sense
MDedge Family Medicine
Clinic goes to bat for bullied kids
MDedge Family Medicine